Comprehensive Analysis of Breast Reconstruction Techniques: Surgical Approaches, Patient Outcomes, and Advancements in Oncoplastic Surgery
Main Article Content
Abstract
Breast reconstruction following mastectomy is a critical aspect of the multidisciplinary management of breast cancer, significantly impacting patients' psychological and physical well-being. This review explores the various surgical techniques available for breast reconstruction, including autologous tissue reconstruction and implant-based methods. The article delves into the indications, contraindications, advantages, and potential complications associated with each approach. Furthermore, we examine the role of oncoplastic surgery in enhancing aesthetic outcomes while ensuring oncological safety. Advances in microsurgical techniques, the development of acellular dermal matrices, and the use of 3D imaging and printing technology are highlighted. The review also addresses patient selection criteria, preoperative planning, and postoperative care to optimize outcomes. By providing a comprehensive overview of contemporary practices and emerging innovations, this article aims to guide clinicians in the optimal management of breast reconstruction and to inform patients about their reconstructive options.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
I. Facts and figures | breast cancer UK. Available at: https://www.breastcanceruk.org.uk/about-breast-cancer/facts-figures-and-qas/facts-and-figures/.
II. Breast cancer. Available at: https://www.who.int/news-room/fact-sheets/detail/breast-cancer.
III. Breast cancer statistics and facts | breast cancer now. Available at: https://breastcancernow.org/about-us/media/facts-statistics.
IV. Group on Hormonal Factors in Breast Cancer C . Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence. Lancet (2019) 394(10204):1159–68. doi: 10.1016/S0140-6736(19)31709-X
V. Beral V, Peto R, Pirie K, Reeves G. Menopausal hormone therapy and 20-year breast cancer mortality. Lancet (2019) 394(10204):1139. doi: 10.1016/S0140-6736(19)32033-1
VI. Ravdin PM, Cronin KA, Howlader N, Berg CD, Chlebowski RT, Feuer EJ, et al.. The decrease in breast-cancer incidence in 2003 in the united states. N Engl J Med (2007) 356(16):1670–4. doi: 10.1056/NEJMsr070105
VII. Banks E, Canfell K. Recent declines in breast cancer incidence: mounting evidence that reduced use of menopausal hormones is largely responsible. Breast Cancer Res (2010) 12(1):1–3. doi: 10.1186/bcr2463
VIII. Mcdonald JA, Goyal A, Terry MB. Alcohol Intake and Breast Cancer Risk: Weighing the Overall Evidence. Curr Breast Cancer Rep. (2013) 5(3):10.1007/s12609-013-0114-z. doi: 10.1007/s12609-013-0114-z
IX. Seitz HK, Pelucchi C, Bagnardi V, Vecchia C. REVIEW epidemiology and pathophysiology of alcohol and breast cancer. Available at: https://academic.oup.com/alcalc/article/47/3/204/145832.
X. Smith-Warner SA, Spiegelman D, Yaun SS, van den Brandt PA, Folsom AR, Goldbohm RA, et al.. Alcohol and breast cancer in women: a pooled analysis of cohort studies. JAMA (1998) 279(7):535–40. doi: 10.1001/jama.279.7.535
XI. Williams LA, Olshan AF, Tse CK, Bell ME, Troester MA. Alcohol intake and invasive breast cancer risk by molecular subtype and race in the Carolina breast cancer study. Cancer Causes Control (2016) 27(2):259–69. doi: 10.1007/s10552-015-0703-4
XII. Klintman M, Rosendahl AH, Randeris B, Eriksson M, Czene K, Hall P, et al.. Postmenopausal overweight and breast cancer risk; results from the KARMA cohort. Breast Cancer Res Treat (2022) 196(1):185–96. doi: 10.1007/s10549-022-06664-7
XIII. Neuhouser ML, Aragaki AK, Prentice RL, Manson JAE, Chlebowski R, Carty CL, et al.. Overweight, obesity, and postmenopausal invasive breast cancer risk: a secondary analysis of the women’s health initiative randomized clinical trials. JAMA Oncol (2015) 1(5):611–21. doi: 10.1001/jamaoncol.2015.1546